Laza Medical
Generated 5/9/2026
Executive Summary
Laza Medical is a private medical technology company based in San Diego, developing an AI-powered robotic cardiac imaging system aimed at simplifying and automating ultrasound guidance for structural heart and electrophysiology procedures. The platform is designed to increase clinician autonomy and expand patient access to complex cardiac interventions. Founded in 2018, the company operates in the AI/machine learning space and targets a significant unmet need in interventional cardiology, where precise imaging is critical but often requires specialized expertise. While specific financials and stage details are undisclosed, Laza Medical's focus on AI-driven automation positions it well in the growing market for robotic-assisted medical devices. The company's progress likely depends on securing additional funding, achieving regulatory milestones, and validating its technology in clinical settings. With the rising adoption of minimally invasive cardiac procedures, Laza Medical's solution could address key bottlenecks in workflow efficiency and procedural consistency.
Upcoming Catalysts (preview)
- Q4 2026Series B or C funding round70% success
- Q3 2026FDA 510(k) clearance or CE mark for the imaging system60% success
- Q2 2027Publication of pivotal clinical trial results50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)